Frazier Healthcare Partners
Est. dry powder
$3.1B
Raised, not yet invested
AUM
$6.9B
Assets under management
Latest fund
$5M
Frazier Portfolio Fund
Est. cheque size
$2.3M–
From fund sizes
Deals, last 12 months
12
Last seen investing Jul 2026
About Frazier Healthcare Partners
Frazier Healthcare Partners is a U.S.-based private equity firm that follows a two-pronged investment model, investing in early-stage biotech, medical devices, and other healthcare venture opportunities, as well as growth equity opportunities in EBITDA-positive healthcare companies. The firm’s geographic focus includes the United States, North America, Europe, and select global markets. Its affiliated platform, Frazier Life Sciences, focuses on companies developing novel therapeutics and invests across all stages of drug development through its dedicated life sciences funds.
- Type
- Private Equity Firm
- Headquarters
- Seattle, Washington, US
- Stages
- SeedSeries ASeries BSeries CSeries DSeries ESeries FSeries G+3
- Est. cheque size
- $2.3M–$30.8M
- Sectors
- Healthcare, Diversified
- Regions
- North America
- Strategies
- Buyout
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- Series A79
- Series B63
- Series C47
- —33
- Series D27
Across 321 deals
Portfolio sectors
- Biotechnology56
- Pharmaceuticals25
- Healthcare6
- Healthcare IT4
- —1
Across 180 companies
Portfolio countries
- US88
- UK4
- Switzerland2
- Canada1
- China1
Across 180 companies
Recent investments
Newest 5 of 321
- —$707M
MatrixCare, Inc.
Jul 2026 · —
- —$490M
MatrixCare, Inc.
Jun 2026 · —
- Series A$112.9M
RQ Biotechnology Ltd.
Jun 2026 · Series A
- —$179.6M
Achieve Life Sciences, Inc.
Apr 2026 · —
- Series B$137M
Sidewinder Therapeutics, Inc.
Apr 2026 · Series B
Offices
4 locations
- Seattle, Washington, USHQ
- Palo Alto, California, US
- San Diego, California, US
- New York, New York, US